The progress of Mycobacterium tuberculosis drug targets

被引：1
|
作者：
Zhang, Xin [1 ]
Zhao, Ruixia [1 ]
Qi, Yao [1 ]
Yan, Xiong [1 ]
Qi, Gaoxiu [1 ]
Peng, Qiuju [2 ]
机构：
[1] Univ Hlth & Rehabil Sci, Qingdao Cent Hosp, Qingdao Cent Med Grp, Qingdao, Shandong, Peoples R China
[2] Qingdao Chest Hosp, Qingdao, Shandong, Peoples R China
来源：
FRONTIERS IN MEDICINE | 2024年 / 11卷
关键词：
<italic>Mycobacterium tuberculosis</italic>; anti-tuberculosis drug; target; cell wall synthesis correlation; DNA/RNA synthesis correlation; energy metabolism; DEPENDENT REGULATOR IDER; HOST-IMMUNE-RESPONSE; INHIBITORS; POTENT; DESIGN; SQ109; DISCOVERY;
D O I：
10.3389/fmed.2024.1455715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tuberculosis (TB) has been troubling humans for hundreds of years, is a highly infectious disease caused by Mycobacterium tuberculosis (Mtb) infection, Mtb can infect almost all organs of the body and is one of the deadly infectious diseases in the world. At present, the first-line treatment regimen has a long treatment cycle and is prone to multiple drug resistance. Anti-tuberculosis drugs and latent tuberculosis infection (LTBI) resistance are increasing year by year, and new targets and new bioactive compounds are urgently needed to treat this disease. This review focuses on the latest reported anti-TB drug targets and related compounds in recent years, reviews the current TB drug regimen and major defects, outlines the key drug targets developed to date in Mtb, and the current situation of newly discovered anti-TB resistant forms of drugs. To provide a reference for the research and development of new anti-TB drugs and bring new treatment strategies for TB patients.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Identification of Missing Carbon Fixation Enzymes as Potential Drug Targets in Mycobacterium Tuberculosis
    Katiyar, Amit
    Singh, Harpreet
    Azad, Krishna Kant
    JOURNAL OF INTEGRATIVE BIOINFORMATICS, 2018, 15 (03)
  • [32] Tuberculosis drug targets
    Zhang, Y
    Amzel, LM
    CURRENT DRUG TARGETS, 2002, 3 (02) : 131 - 154
  • [33] Comparative analyses of the proteins from Mycobacterium tuberculosis and human genomes: Identification of potential tuberculosis drug targets
    Sridhar, Settu
    Dash, Pallabini
    Guruprasad, Kunchur
    GENE, 2016, 579 (01) : 69 - 74
  • [34] Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
    Yang, Jiaxing
    Zhang, Laiying
    Qiao, Wenliang
    Luo, Youfu
    MEDCOMM, 2023, 4 (05):
  • [35] Progress for deciphering Mycobacterium tuberculosis pathogenicity
    Reyrat, JM
    Gicquel, B
    MULTI-DRUG RESISTANCE IN EMERGING AND RE-EMERGING DISEASES, 2000, : 125 - 132
  • [36] Progress in diagnosis and epidemiology of Mycobacterium tuberculosis
    Augustynowicz-Kopec, Ewa
    Zwolska, Zofia
    POSTEPY MIKROBIOLOGII, 2010, 49 (03): : 151 - 156
  • [37] Progress in serodiagnosis of Mycobacterium tuberculosis infection
    Abebe, F.
    Holm-Hansen, C.
    Wiker, H. G.
    Bjune, G.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (2-3) : 176 - 191
  • [38] An In silico Approach to Identify Potential Inhibitors against Multiple Drug Targets of Mycobacterium tuberculosis
    Kumar, Satish
    Sahu, Parameswar
    Jena, Lingaraja
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (03) : 252 - 261
  • [39] Drug resistance in Mycobacterium tuberculosis
    Johnson, Rabia
    Streicher, Elizabeth M.
    Louw, Gail E.
    Warren, Robin M.
    van Helden, Paul D.
    Victor, Thomas C.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2006, 8 : 97 - 111
  • [40] Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery
    Lou, Zhiyong
    Zhang, Xiaoxue
    PROTEIN & CELL, 2010, 1 (05) : 435 - 442
12345